The effect of folic acid supplementation on plasma homocysteine in an elderly population

J. A. Simpson, Alison Patricia Rydlewicz, Ross Jenkins Taylor, Christine Margaret Bond, Michael Henry Niven Golden

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: increased plasma homocysteine is associated with coronary artery disease, peripheral vascular disease and venous thrombosis. Folic acid is the most effective therapy for reducing homocysteine levels. The lowest effective supplement of folic acid is not known, particularly for the elderly who have the highest prevalence of these conditions.

Aim: To explore the effects of daily supplements of 0, 50, 100, 200, 400 and 600 mug folic acid on plasma homocysteine in an elderly population.

Design: Randomized double-blind placebo-controlled trial.

Methods: Participants (n = 368) aged 65-75 years were randomly allocated to receive one of the treatments for 6 weeks. Plasma homocysteine was recorded after 3 weeks and 6 weeks of supplementation.

Results: Only the 400 mug and 600 mug groups had significantly lower homocysteine levels compared to placebo (p = 0.038 and p < 0.001, respectively). Using multiple linear regression and each individual's total folic acid intake (diet plus supplement), a total daily folic acid intake of 926 mug per day would be required to ensure that 95% of the elderly population would be without cardiovascular risk from folate deficiency.

Discussion: A daily folic acid intake of 926 mug is unlikely to be achieved by diet alone. Individual supplementation or fortification of food with folic acid will be required to reach this target.

Original languageEnglish
Pages (from-to)27-35
Number of pages8
JournalQJM
Volume95
Issue number1
DOIs
Publication statusPublished - Jan 2002

Keywords

  • CORONARY HEART-DISEASE
  • PERFORMANCE LIQUID-CHROMATOGRAPHY
  • SERUM TOTAL HOMOCYSTEINE
  • RISK FACTOR
  • VASCULAR-DISEASE
  • CARDIOVASCULAR-DISEASE
  • MYOCARDIAL-INFARCTION
  • HOMOCYST(E)INE LEVELS
  • METHYLMALONIC ACID
  • VITAMINS

Cite this

Simpson, J. A., Rydlewicz, A. P., Taylor, R. J., Bond, C. M., & Golden, M. H. N. (2002). The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM, 95(1), 27-35. https://doi.org/10.1093/qjmed/95.1.27

The effect of folic acid supplementation on plasma homocysteine in an elderly population. / Simpson, J. A.; Rydlewicz, Alison Patricia; Taylor, Ross Jenkins; Bond, Christine Margaret; Golden, Michael Henry Niven.

In: QJM, Vol. 95, No. 1, 01.2002, p. 27-35.

Research output: Contribution to journalArticle

Simpson, JA, Rydlewicz, AP, Taylor, RJ, Bond, CM & Golden, MHN 2002, 'The effect of folic acid supplementation on plasma homocysteine in an elderly population', QJM, vol. 95, no. 1, pp. 27-35. https://doi.org/10.1093/qjmed/95.1.27
Simpson, J. A. ; Rydlewicz, Alison Patricia ; Taylor, Ross Jenkins ; Bond, Christine Margaret ; Golden, Michael Henry Niven. / The effect of folic acid supplementation on plasma homocysteine in an elderly population. In: QJM. 2002 ; Vol. 95, No. 1. pp. 27-35.
@article{b9bbdd2b650843598e9ebc6eb51acc12,
title = "The effect of folic acid supplementation on plasma homocysteine in an elderly population",
abstract = "Background: increased plasma homocysteine is associated with coronary artery disease, peripheral vascular disease and venous thrombosis. Folic acid is the most effective therapy for reducing homocysteine levels. The lowest effective supplement of folic acid is not known, particularly for the elderly who have the highest prevalence of these conditions.Aim: To explore the effects of daily supplements of 0, 50, 100, 200, 400 and 600 mug folic acid on plasma homocysteine in an elderly population.Design: Randomized double-blind placebo-controlled trial.Methods: Participants (n = 368) aged 65-75 years were randomly allocated to receive one of the treatments for 6 weeks. Plasma homocysteine was recorded after 3 weeks and 6 weeks of supplementation.Results: Only the 400 mug and 600 mug groups had significantly lower homocysteine levels compared to placebo (p = 0.038 and p < 0.001, respectively). Using multiple linear regression and each individual's total folic acid intake (diet plus supplement), a total daily folic acid intake of 926 mug per day would be required to ensure that 95{\%} of the elderly population would be without cardiovascular risk from folate deficiency.Discussion: A daily folic acid intake of 926 mug is unlikely to be achieved by diet alone. Individual supplementation or fortification of food with folic acid will be required to reach this target.",
keywords = "CORONARY HEART-DISEASE, PERFORMANCE LIQUID-CHROMATOGRAPHY, SERUM TOTAL HOMOCYSTEINE, RISK FACTOR, VASCULAR-DISEASE, CARDIOVASCULAR-DISEASE, MYOCARDIAL-INFARCTION, HOMOCYST(E)INE LEVELS, METHYLMALONIC ACID, VITAMINS",
author = "Simpson, {J. A.} and Rydlewicz, {Alison Patricia} and Taylor, {Ross Jenkins} and Bond, {Christine Margaret} and Golden, {Michael Henry Niven}",
year = "2002",
month = "1",
doi = "10.1093/qjmed/95.1.27",
language = "English",
volume = "95",
pages = "27--35",
journal = "QJM",
issn = "1460-2725",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - The effect of folic acid supplementation on plasma homocysteine in an elderly population

AU - Simpson, J. A.

AU - Rydlewicz, Alison Patricia

AU - Taylor, Ross Jenkins

AU - Bond, Christine Margaret

AU - Golden, Michael Henry Niven

PY - 2002/1

Y1 - 2002/1

N2 - Background: increased plasma homocysteine is associated with coronary artery disease, peripheral vascular disease and venous thrombosis. Folic acid is the most effective therapy for reducing homocysteine levels. The lowest effective supplement of folic acid is not known, particularly for the elderly who have the highest prevalence of these conditions.Aim: To explore the effects of daily supplements of 0, 50, 100, 200, 400 and 600 mug folic acid on plasma homocysteine in an elderly population.Design: Randomized double-blind placebo-controlled trial.Methods: Participants (n = 368) aged 65-75 years were randomly allocated to receive one of the treatments for 6 weeks. Plasma homocysteine was recorded after 3 weeks and 6 weeks of supplementation.Results: Only the 400 mug and 600 mug groups had significantly lower homocysteine levels compared to placebo (p = 0.038 and p < 0.001, respectively). Using multiple linear regression and each individual's total folic acid intake (diet plus supplement), a total daily folic acid intake of 926 mug per day would be required to ensure that 95% of the elderly population would be without cardiovascular risk from folate deficiency.Discussion: A daily folic acid intake of 926 mug is unlikely to be achieved by diet alone. Individual supplementation or fortification of food with folic acid will be required to reach this target.

AB - Background: increased plasma homocysteine is associated with coronary artery disease, peripheral vascular disease and venous thrombosis. Folic acid is the most effective therapy for reducing homocysteine levels. The lowest effective supplement of folic acid is not known, particularly for the elderly who have the highest prevalence of these conditions.Aim: To explore the effects of daily supplements of 0, 50, 100, 200, 400 and 600 mug folic acid on plasma homocysteine in an elderly population.Design: Randomized double-blind placebo-controlled trial.Methods: Participants (n = 368) aged 65-75 years were randomly allocated to receive one of the treatments for 6 weeks. Plasma homocysteine was recorded after 3 weeks and 6 weeks of supplementation.Results: Only the 400 mug and 600 mug groups had significantly lower homocysteine levels compared to placebo (p = 0.038 and p < 0.001, respectively). Using multiple linear regression and each individual's total folic acid intake (diet plus supplement), a total daily folic acid intake of 926 mug per day would be required to ensure that 95% of the elderly population would be without cardiovascular risk from folate deficiency.Discussion: A daily folic acid intake of 926 mug is unlikely to be achieved by diet alone. Individual supplementation or fortification of food with folic acid will be required to reach this target.

KW - CORONARY HEART-DISEASE

KW - PERFORMANCE LIQUID-CHROMATOGRAPHY

KW - SERUM TOTAL HOMOCYSTEINE

KW - RISK FACTOR

KW - VASCULAR-DISEASE

KW - CARDIOVASCULAR-DISEASE

KW - MYOCARDIAL-INFARCTION

KW - HOMOCYST(E)INE LEVELS

KW - METHYLMALONIC ACID

KW - VITAMINS

U2 - 10.1093/qjmed/95.1.27

DO - 10.1093/qjmed/95.1.27

M3 - Article

VL - 95

SP - 27

EP - 35

JO - QJM

JF - QJM

SN - 1460-2725

IS - 1

ER -